查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553506

生物活性创伤护理市场规模、份额、趋势分析报告：按产品、按应用、按地区、细分市场预测，2024-2030 年

Bioactive Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial, Active Dressing), By Application (General Surgery, Minimally invasive Surgery), By Region, And Segments Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

生物活性创伤护理市场的成长与趋势：

Grand View Research, Inc.的最新报告显示，到2030年，全球生物活性创伤护理市场预计将达到184亿美元，2024年至2030年复合年增长率为7.4%。

压力性溃疡、糖尿病足和其他皮肤相关感染疾病等慢性皮肤病的盛行率正在增加。生物活性创伤护理产品提供了有效治疗上述病症的有效治疗方法。

因此，随着目标人口的增加，生物活性创伤护理市场预计将出现利润丰厚的成长。患者个人卫生意识的提高正在增加对这些产品的需求。意识层级的提高鼓励患者儘早寻求医疗建议，以便及时介入。

近年来，人均医疗保健支出增加，可支配收入增加，使公民可以在医疗保健设施上花费更多，从而促进市场成长。先进产品的开发，例如含有多种成分的组合伤口敷料，可为患者提供多种好处，预计将推动对这些产品的需求。

生物活性创伤护理市场报告亮点

  • 湿性创伤护理占市场主导地位，2023年占61.1%的份额。湿润的伤口敷料可保持适当的湿度，防止脱水，促进细胞迁移，创造最佳的癒合环境并加速伤口缝合。
  • 2023 年，一般外科占据最大的市场收益占有率，达到 68.6%。普通外科领域进一步分为整形外科、皮肤科、小儿科和其他应用。
  • 北美生物活性创伤护理市场主导全球生物活性创伤护理市场，2023年收益占有率为42.6%。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章生物活性创伤护理市场变数、趋势和范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 生物活性创伤护理市场分析工具
    • 波特的分析
    • PESTEL分析

第四章生物活性创伤护理市场：产品评估与趋势分析

  • 细分仪表板
  • 生物活性创伤护理市场：产品变化分析，百万美元，2023-2030
  • 湿润创伤护理
  • 抗菌创伤护理
  • 主动穿衣

第五章生物活性创伤护理市场：应用估算与趋势分析

  • 细分仪表板
  • 生物活性创伤护理市场：应用变化分析，百万美元，2023-2030
  • 一般外科
  • 微创手术

第六章生物活性创伤护理市场：区域估计和趋势分析

  • 生物活性创伤护理市场占有率（按地区），2023 年和 2030 年，百万美元
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 最新趋势与影响分析：主要市场参与企业
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • B. Braun SE
    • Essity Health &Medical
    • 3M
    • Convatec Group PLC
    • Covalon Technologies Ltd
    • DermaRite Industries LLC
    • Hollister Incorporated
    • Integra LifeSciences Corporation
    • Johnson &Johnson Services, Inc.
    • Medtronic
    • Monlnlycke Health Care AB
    • Smith+Nephew
简介目录
Product Code: GVR-1-68038-081-1

Bioactive Wound Care Market Growth & Trends:

The global bioactive wound care market is expected to reach USD 18.4 billion by 2030 and expanding at a CAGR of 7.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. The prevalence of chronic skin conditions, such as pressure ulcers, diabetic foot, and other skin-related infections is on the rise. Bioactive wound care products offer available line of treatment, which act efficiently in curing the aforementioned conditions.

Hence, with the increasing target population, the bioactive wound care market is estimated to witness lucrative growth. Rise in awareness among the patients regarding personal hygiene is augmenting the demand for these products. The raised awareness levels cause patients to seek physicians' advice at an early stage thus enabling timely interventions.

Rising per capita healthcare expenditure in the recent years and the increasing disposable income is enabling the population to spend a substantial amount on healthcare facilities, thereby contributing towards the growth of the market. The development of advanced products, such as combination wound dressings containing multiple ingredients that offer several benefits to patients, is anticipated to boost the demand for these products.

Bioactive Wound Care Market Report Highlights:

  • Moist wound care dominated the market and accounted for a share of 61.1% in 2023. Moist wound dressings create an optimal healing environment by maintaining the right moisture level, preventing dehydration, and promoting cell migration for faster closure.
  • General surgery accounted for the largest market revenue share of 68.6% in 2023. The general surgery segment is further classified into plastic, dermatological, pediatric and others applications.
  • North America bioactive wound care market dominated the global bioactive wound care market with a revenue share of 42.6% in 2023, driven by the existence of a substantial number of individuals with diabetes and the quick acceptance of modern wound treatment methods.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Bioactive Wound Care Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Bioactive Wound Care Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Bioactive Wound Care Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Bioactive Wound Care Market: Product Movement Analysis, USD Million, 2023 & 2030
  • 4.3. Moist Wound Care
    • 4.3.1. Moist Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.1. Foam
        • 4.3.1.1.1. Foam Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.2. Alginate
        • 4.3.1.2.1. Alginate Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.3. Film
        • 4.3.1.3.1. Film Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.4. Hydrocolloid
        • 4.3.1.4.1. Hydrocolloid Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.5. Hydrogel
        • 4.3.1.5.1. Hydrogel Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Antimicrobial Wound Care
    • 4.4.1. Antimicrobial Wound Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.1. Silver Based
        • 4.4.1.1.1. Silver Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.2. Non-Silver Based
        • 4.4.1.2.1. Non-Silver Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Active Dressing
    • 4.5.1. Active Dressing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.1. Biomaterial
        • 4.5.1.1.1. Biomaterial Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.5.1.2. Skin Substituents
        • 4.5.1.2.1. Skin Substituents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Bioactive Wound Care Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Bioactive Wound Care Market: Application Movement Analysis, USD Million, 2023 & 2030
  • 5.3. General Surgery
    • 5.3.1. General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.1.1. Plastic
        • 5.3.1.1.1. Plastic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.1.2. Dermatological
        • 5.3.1.2.1. Dermatological Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.1.3. Pediatric
        • 5.3.1.3.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 5.3.1.4. Others
        • 5.3.1.4.1. Others General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Minimally Invasive Surgery
    • 5.4.1. Minimally Invasive Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Bioactive Wound Care Market: Regional Estimates & Trend Analysis

  • 6.1. Bioactive Wound Care Market Share, By Region, 2023 & 2030, USD Million
  • 6.2. North America
    • 6.2.1. North America Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Bioactive Wound Care Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. B. Braun SE
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/Strategic Initiatives
    • 7.4.2. Essity Health & Medical
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/Strategic Initiatives
    • 7.4.3. 3M
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/Strategic Initiatives
    • 7.4.4. Convatec Group PLC
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/Strategic Initiatives
    • 7.4.5. Covalon Technologies Ltd
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/Strategic Initiatives
    • 7.4.6. DermaRite Industries LLC
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/Strategic Initiatives
    • 7.4.7. Hollister Incorporated
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/Strategic Initiatives
    • 7.4.8. Integra LifeSciences Corporation
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/Strategic Initiatives
    • 7.4.9. Johnson & Johnson Services, Inc.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/Strategic Initiatives
    • 7.4.10. Medtronic
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/Strategic Initiatives
    • 7.4.11. Monlnlycke Health Care AB
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/Strategic Initiatives
    • 7.4.12. Smith+Nephew
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/Strategic Initiatives